Anika Therapeutics ANIK
NASDAQ ANIK
$13.95 +0.48 (+3.56%)
At close: Nov 11, 2026 · 4:00 PM EST

Anika Therapeutics (ANIK) Return on Sales [ROS] (2009 - 2026)

Updated

Anika Therapeutics (ANIK) recorded Return on Sales [ROS] of 9.06% in Q2 2026, up 23.87 percentage points from -14.81% a year earlier and up 27.59 percentage points from the prior quarter.

Analysis

Anika Therapeutics (ANIK) Return on Sales [ROS] (2009 - 2026) Analysis & Trends

On a TTM basis, Anika Therapeutics' Return on Sales [ROS] came in at -4.24% as of Jun 30, 2026, up 3.83 percentage points year-over-year; for FY2025, it was -9.80%, down 5.54 percentage points from FY2024.

  • Annual Return on Sales [ROS] has declined for three straight years, though with a five-year change of +11.91 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Sales [ROS] came in at -4.25% in FY2024 (-4.95 pp), 0.70% in FY2023 (-2.53 pp), 3.22% in FY2022 (+1.45 pp) and 1.77% in FY2021 (+23.48 pp).
  • The Q2 2026 figure is the highest quarterly Return on Sales [ROS] since Q2 2021.
  • On a year-over-year basis, Return on Sales [ROS] rose in three of the last eight quarters, with an average year-over-year change of +1.67 percentage points.
  • Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 29.45 percentage points in Q4 2021, against a drop of 32.59 percentage points in Q2 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at -18.53% (Q1 2026), 2.11% (Q4 2025) and -11.62% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn 18.65%
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn 10.44%
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn 19.00%
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn 19.44%
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn 18.08%
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn 15.86%
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn 16.12%
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn 17.44%
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn 6.36%
10 Anika Therapeutics 180.43 Mn -104.21 Mn 18.84 Mn -2.33%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -2.33%
Jun 30, 2026 9.06%
Mar 31, 2026 -18.53%
Dec 31, 2025 2.11%
Sep 30, 2025 -11.62%
Jun 30, 2025 -14.81%
Mar 31, 2025 -16.37%
Dec 31, 2024 -2.30%
Sep 30, 2024 -0.27%
Jun 30, 2024 -5.89%
Mar 31, 2024 -8.63%
Dec 31, 2023 0.70%
Sep 30, 2023 -18.51%
Jun 30, 2023 -8.20%
Mar 31, 2023 -33.10%
Dec 31, 2022 3.22%
Sep 30, 2022 -14.40%
Jun 30, 2022 -8.53%
Mar 31, 2022 -9.69%
Dec 31, 2021 -25.47%
API Access

Anika Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ANIK&period=max&api_key=YOUR_API_KEY